Key Points
- This research aims to determine how endothelin-1 affects regional blood flow in the kidneys, focusing on medullary and cortical areas.
- Measured cortical blood flow (CBF) and medullary blood flow (MBF) using laser-Doppler flowmetry in anesthetized Wistar rats.
- Administered endothelin-1 at 1.0 nmol/kg intravenously and evaluated effects on blood flow.
- Examined the impact of nitric oxide blockade with L-NAME and cyclooxygenase inhibition with indomethacin on ET-1 effects.
- Endothelin-1 administration decreased CBF by 20% and increased MBF by 24%.
- L-NAME blockade reversed the increase in MBF (delta = -19%) and intensified CBF reduction (delta = -31%).
- Indomethacin treatment reduced the MBF increase by 12% but did not impact CBF changes.
Structured PICO
PPopulationAnesthetized Wistar rats
IInterventionEndothelin-1 (ET-1) 1.0 nmol/kg i.v., with or without nitric oxide blockade (L-NAME) or cyclooxygenase inhibition (indomethacin)
OOutcomeMedullary and cortical blood flow (MBF and CBF) measured simultaneously by laser-Doppler flowmetrysurrogate
Endothelin-1 exerts differential effects on renal regional blood flow, causing cortical vasoconstriction and medullary vasodilation, the latter being dependent on nitric oxide and prostaglandins.